DCT
1:20-cv-00804
Sanofi Aventis US LLC v. Apotex Corp
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (08/02/23)
Patent Owner
NPE (W)
PACER1:20-cv-00804
Nature of Suit835 ANDA
Appeals23-2264
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
-- | 36% |
Plaintiff
Party
Name | Ratings |
|---|---|
L5B | |
L5B | |
L5B | |
Be Labs Inc NPE | ---- -- |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L4A | |
L5A | |
L5B | |
L4A | |
L3B | |
---- -- | |
---- -- | |
L4A | |
L4B | |
L3E | |
---- -- | |
Jacobs & Crumplar PALocal | ---- -- |
---- -- | |
Attorney at LawLocal | ---- -- |
---- -- |
Defendant
Party
Name | Ratings |
|---|---|
L5E | |
L5A | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L4E | |
L3E | |
L3E | |
L1C | |
L1E | |
L1E | |
---- -- |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L5E | |
L5B | |
L5A | |
L4A | |
L4D | |
L3C | |
L5D | |
L5E | |
L2C | |
L5D | |
L5A | |
L5C | |
L5D | |
L4C | |
L3D | |
L3E | |
L2C | |
L2D | |
L4B | |
L5A | |
L5C | |
L4B | |
Shaw Keller LLPLocal | L4E |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L5E | |
L5E | |
L3D | |
L5B | |
---- -- | |
L3E | |
L5E | |
L3E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
---- -- | |
---- -- | |
L3E | |
L5E | |
L3E | |
L5E | |
L5E | |
L2C | |
L5B | |
L5E | |
L5E | |
L2E | |
L5B | |
L5C | |
---- -- |